Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8785018 | Advances in Radiation Oncology | 2017 | 20 Pages |
Abstract
In this modern series of patients with resected stage III (N2) NSCLC, patients who received PORT had higher rates of OS and LRC, but these differences were not statistically significant.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
William G. BA, Kenneth W. MD, Aaron S. MD, Dennis A. MD PhD, Yolanda I. MD, Sean S. MD PhD, Kenneth R. MD, Christopher L. MD,